MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-26-0183651
Meditm Pharmaceuticals Private Limited
Meditm Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹41.41 Lakh
▲ 4% YoY
Net loss · FY 2025
₹5.64 Lakh
Net margin -13.6%
EBITDA · FY 2025
-₹4.54 Lakh
EBITDA margin -11%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Meditm Pharmaceuticals Private Limited
Data last updated:
Meditm Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85100PN2021PTC204643. Its GSTIN is 27AAPCM0096C1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suraj Sudhir Mutkule and Priyanka Namdev Amle.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sr No.59/2 Fl No 302 – A Wing Lake Homes Jambhulwadi Bridge Ambegaon Kh Pune, Maharashtra, India – 411046.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.41 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹5.64 Lakh (net margin -13.6%) and EBITDA of -₹4.54 Lakh (EBITDA margin -11%). Revenue has grown at a compounded annual rate (CAGR) of 160% over three years.
Meditm Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0183651).
Company details
CIN U85100PN2021PTC204643
Registration Number 204643
Incorporation Date 27 September 2021
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-26-0183651
Recognitions & Rankings of Meditm Pharmaceuticals
Contact details
Meditm Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSr No.59/2 Fl No 302 – A Wing Lake Homes Jambhulwadi Bridge Ambegaon Kh Pune, Maharashtra, India – 411046
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Meditm Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Meditm Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Meditm Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Meditm Pharmaceuticals Private Limited, buy the company report.
Financials of Meditm Pharmaceuticals Private Limited
FY 2025 filings availableMeditm Pharmaceuticals Private Limited reported revenue of ₹41.41 Lakh (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹41.41 Lakh ▲ 4%
Net loss · FY 2025
₹5.64 Lakh margin -13.6%
EBITDA · FY 2025
-₹4.54 Lakh margin -11%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 160%
EBITDA CAGR growth
1 year
▲ 41%
3 years · compounded
▼ 206%
Revenue has grown at a compounded annual rate (CAGR) of 160% over three years, including 4% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹4.54 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹5.64 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -11% | |||
| Net Profit Margin | -13.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Meditm Pharmaceuticals Private Limited, buy the company report.
Board of directors of Meditm Pharmaceuticals Private Limited
Meditm Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suraj Sudhir Mutkule | Director | 27 Sep 2021 | 5 Years 1 Months | Current |
| Priyanka Namdev Amle | Additional Director | 27 Mar 2024 | 2 Years 7 Months | Current |
Auditor
Meditm Pharmaceuticals Private Limited is audited by AGHAV & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGHAV & COMPANY | FY 2023 | 152396 |
Shareholding
The shareholding of Meditm Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Meditm Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Meditm Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meditm Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Meditm Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
Active EPFO establishments
1
GST
Meditm Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCM0096C1ZF | Maharashtra | Active | 20 Oct 2021 |
To see the full GST registrations and return filing status of Meditm Pharmaceuticals Private Limited, buy the company report.
Recent activity
Meditm Pharmaceuticals Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Avinash Ramchandra Sonalkar ceased to be Director on 28 Mar 2024.
AGM
Meditm Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Meditm Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Avinash Ramchandra Sonalkar ceased to be Director.
Appointed
Priyanka Namdev Amle was appointed as Additional Director.
Appointed
Avinash Ramchandra Sonalkar was appointed as Director.
Appointed
Suraj Sudhir Mutkule was appointed as Director.
Incorporation
27 Sep 2021
Meditm Pharmaceuticals Private Limited was registered on 27 Sep 2021 with Roc Pune & aged 5 years 1 month as per MCA records.
Frequently asked questions
Meditm Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 September 2021 (5+ years old) and is registered under CIN U85100PN2021PTC204643.
Meditm Pharmaceuticals has 2 current directors:
- Suraj Sudhir Mutkule - Director
- Priyanka Namdev Amle - Additional Director
The latest financial statements of Meditm Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Meditm Pharmaceuticals is 27AAPCM0096C1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Meditm Pharmaceuticals is U85100PN2021PTC204643. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meditm Pharmaceuticals was incorporated on 27 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
Avinash Ramchandra Sonalkar ceased to be Director on 28 Mar 2024. Priyanka Namdev Amle was appointed as Additional Director on 27 Mar 2024. Avinash Ramchandra Sonalkar was appointed as Director on 27 Sep 2021. Meditm Pharmaceuticals has 4 board changes on record in total.
Yes, Meditm Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0183651).
The registered office of Meditm Pharmaceuticals is at Sr No.592 Fl No 302 – A Wing Lake Homes Jambhulwadi Bridge Ambegaon Kh Pune, Maharashtra, India – 411046.
Meditm Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages